Close this search box.


Sequencing the genomes of up to 10,000 patients diagnosed with COVID-19 (the “hosts”)
CanCOGeN HostSeq

COVID-19 displays significant inter-individual clinical variability, ranging from silent infection to lethal disease. We therefore need to characterize the role of human genetics in determining clinical response.

This work, comprising a series of cohort-based sub projects, aims to better characterize the role of human genetics in COVID-19 disease, deliver new biomarkers that predict people at highest risk, and implement appropriate healthcare strategies, including potential precision therapies.

As Canada’s national facility for genome sequencing and analysis, CGEn is leading HostSeq, working with partners across the country. CGEn is mandated to develop regional, national, and international linkages to ensure that this investment has maximal impact for the health of all Canadians.

The work of CanCOGeN's HostSeq Project

For additional information about CanCOGen HostSeq,
visit the CGEn website.

HostSeq: A Canadian COVID-19 Human Host Genome Sequencing Initiative

Webinar – November 6, 2020

This webinar will:

  • Introduce you to the Canadian COVID-19 Genomics Network (CanCOGeN) and its host sequencing initiative (HostSeq) which will sequence the genomes of up to 10,000 patients diagnosed with COVID-19.
  • Explore opportunities to partner with HostSeq in its work to tackle the COVID-19 challenge and advance your own research program.
  • Provide an opportunity to hear from and engage with Dr. Catalina Lopez-Correa, Executive Director, CanCOGeN, Dr. Naveed Aziz, Chief Administrative Officer & Chief Scientific Officer, CGEn and Dr. Stuart Turvey, Canada Research Chair in Pediatric Precision Health & Chair, HostSeq Recruitment.